1. Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives
   Shinya Matsuzaki et al, 2015, Cancer Cell International CrossRef
2. Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
   PENG SONG et al, 2015, Experimental and Therapeutic Medicine CrossRef
3. Cross-reacting material 197, a heparin-binding EGF-like growth factor inhibitor, reverses the chemoresistance in human cisplatin-resistant ovarian cancer
   Xiao-han Tang et al, 2014, Anti-Cancer Drugs CrossRef
4. Investigating the Frequency of the ERCC1 Gene C8092A Polymorphism in Iranian Patients with Advanced Gastric Cancer
   Sharareh Mokmeli et al, 2016, Asian Pacific Journal of Cancer Prevention CrossRef
5. Influence of ERCC1 and ERCC4 polymorphisms on response to prognosis in gastric cancer treated with FOLFOX-based chemotherapy
   Zheng-mao Lu et al, 2014, Tumor Biology CrossRef
6. Antiproliferative activity of rosamultic acid is associated with induction of apoptosis, cell cycle arrest, inhibition of cell migration and caspase activation in human gastric cancer (SGC-7901) cells
   Cheng-Guang Sui et al, 2015, Phytomedicine CrossRef
7. A newly established monoclonal antibody against ERCC1 detects major isoforms of ERCC1 in gastric cancer
   Takayuki Oishi et al, 2021, Global Health & Medicine CrossRef
8. Predictive value of excision repair cross-complementation group 1 expression for platinum-based chemotherapy and survival in gastric cancer: a meta-analysis
   Anqi Yao et al, 2014, Journal of Cancer Research and Clinical Oncology CrossRef
9. The clinical value of aberrant epigenetic changes of DNA damage repair genes in human cancer
   Dan Gao et al, 2016, Oncotarget CrossRef
10. MeCP2 confers 5-fluorouracil resistance in gastric cancer via upregulating the NOX4/PKM2 pathway
    Yannan Qin et al, 2022, Cancer Cell International CrossRef
11. How Prognostic and Predictive Biomarkers Are Transforming Our Understanding and Management of Advanced Gastric Cancer
    Christina Kim et al, 2014, The Oncologist CrossRef
12. H3K27 acetylation activated‐CD109 evokes 5‐fluorouracil resistance in gastric cancer via the JNK/MAPK signaling pathway
    Fei Zhou et al, 2023, Environmental Toxicology CrossRef
13. Cthrc1 overexpression is an independent prognostic marker in gastric cancer
    Lina Gu et al, 2014, Human Pathology CrossRef
14. Class III β-tubulin is a predictive marker for taxane-based chemotherapy in recurrent and metastatic gastric cancer
    Jun-Eul Hwang et al, 2013, BMC Cancer CrossRef
15. ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy
    Grazia Palomba et al, 2014, Journal of Translational Medicine CrossRef
16. The prognostic value of ERCC1 expression in gastric cancer patients treated with platinum-based chemotherapy: a meta-analysis
    Kong-Kong Wei et al, 2014, Tumor Biology CrossRef
17. Pt(II) and Pd(II) complexes with a thiazoline derivative ligand: Synthesis, structural characterization, antiproliferative activity and evaluation of pro-apoptotic ability in tumor cell lines HT-29 and U-937
    Elena Fernández-Delgado et al, 2020, Journal of Inorganic Biochemistry CrossRef
18. Higher anti‐tumour efficacy of platinum(IV) complex LA‐12 is associated with its ability to bypass M‐phase entry block induced in oxaliplatin‐treated human colon cancer cells
    O. Vondálová Blanářová et al, 2013, Cell Proliferation CrossRef
19. Establishment of a first-line second-line treatment model for human pulmonary adenocarcinoma
    Lining Wang et al, 2016, Oncology Letters CrossRef
20. ERCC1-expressing circulating tumor cells as a potential diagnostic tool for monitoring response to platinum-based chemotherapy and for predicting post-therapeutic outcome of ovarian cancer
    Issam Chebouti et al, 2017, Oncotarget CrossRef
21. Altered DNA repair creates novel Alu/Alu repeat‐mediated deletions
    Maria E. Morales et al, 2021, Human Mutation CrossRef
22. ERCC1 plays an important role in predicting survival outcomes and treatment response for patients with HNSCC: A meta-analysis
    Ma Xuelei et al, 2015, Oral Oncology CrossRef
23. ERCC1-Positive Circulating Tumor Cells in the Blood of Ovarian Cancer Patients as a Predictive Biomarker for Platinum Resistance
    Jan Dominik Kuhlmann et al, 2014, Clinical Chemistry CrossRef
24. Expression of XPG Protein in the Development, Progression and Prognosis of Gastric Cancer
    Na Deng et al, 2014, PLoS ONE CrossRef